title: Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer.
authors.affiliation: Feinberg School of Medicine at Northwestern University, Chicago, Illinois.
authors.forename: William J
authors.initials: WJ
authors.lastname: Gradishar
authors.forename: Christopher
authors.initials: C
authors.lastname: Twelves
authors.forename: Hope S
authors.initials: HS
authors.lastname: Rugo
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy*; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D005260:Female; D005663:Furans / Q000627:therapeutic use; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D058990:Molecular Targeted Therapy / Q000379:methods; D057285:Precision Medicine; D064726:Triple Negative Breast Neoplasms / Q000628:therapy; D050257:Tubulin Modulators / Q000627:therapeutic use; D000095662:Polyether Polyketides
chemical_list: D005663:Furans; D007659:Ketones; D050257:Tubulin Modulators; C490954:eribulin; D000095662:Polyether Polyketides